Document bOE7q2B9LjeDBjjVVw4nLJbY3

romance ree comaTon eTooRyAer ro PHsnc Lsee nuootismmT geermeer bl(o51t3) a3t57a.n0c8o%m TAFT, STETTINIUS & HOLLISTER LLP 425 WALNUT STREET, SUITE 1800 CINCINNATI, OHIO 45202-3957 FAXs:u51s3a36n10208 onto AR 226 December 5, 2003 TELECOPY AND FEDERAL EXPRESS ang omaree Pt 1544 ak coSl isotnseomme fics. Dr. Charles M. Auer Chemical Control Division Officeof Prevention, Pesticides and Toxic Substances UniAtgeedncSytates Environmental Protection 1201 Constitution Avenue, N.W. Room 3166A `Washington, DC 20004 Jennifer Seed United States Environmental Protection Agency 1201 Constitution Avenue, N.W. Room 6334A Washington, DC 20004 Oscar Hemandez Director, Risk Assessment Division Office of Prevention, Pesticides and Toxic Substances UniAtgeedncSytates Environmental Protection 1201 Constitution Avenue, N.W. Room 6220A Washington, DC 20004 John Wheeler, Ph.D. ATSDR 1825 Century Center Blvd. Room 2129 Atlanta, GA 30345 : = = 83 o32n = 23 = B= =: #55 = 2 Re: Human Health Threat Arising From Releases Of PFOA/APFO/C-8 In Ladies and Gentlemen: As a follow up to our letters ofFebruary 3, April 4, April 11, May 6, and May 21, 2003 (AR-226-1216, 1307, 1308, `Washington Works Plant of 1495, and 1493), regarding the health threat to those living E.I duPont de Nemours and Company ("DuPont") located near the in Wood County, West `evaluation of Virginia, the health we have enclosed copies ofthe following condition ofworkers at that DuPont Plant documents relating to DuPont's where PFOA has been used in tdhreinmkainnugfwaactteurr:ing processes since the early 1950s and has been present in the air andplant Women) Dr. Charles M. Auer Oscar Hemandez Jennifer Seed John Wheeler, Ph.D. December 5, 2003 I. DuPont Internal Memo, "Washington Works Cancer Incidence and Overall Mortality Rates" (12/14/89) (EID521382-92); 2. DuPont Internal Memo, "Washington Works - Surveillance Data: Mortality and Cancer Incidence (8/28/92) (EID521393-401); 3 DuPont Internal Memo, "Washington Works - Surveillance Data: Cancer Incidence" (9/28/92)(EIDS521402-3); 4. DuPont Internal Memo, "Mortality and Cancer Incidence Surveillance Updates" (9/26/92) (EID521404-5); and 5 Several internal DuPont Washington Works documents regarding claims of infertility among male employees at DuPont's Washington Works Plant (1984) (EIDS523009-21). Aeptmly 7 " | a9h C . { y, RAB/mdm Fy, Enclosure cc: R. Edison Hill, Esq. (w/o encls.) GeralJd. Rapien, Esq. (w/o encls.) Mary Dominiak (USEPA, OPPT) (for inclusion in AR-226) (w/ encls.) (Fax & FedEx) v Severalofthe pages are marked "Redacted" by DuPont to indicate that employee names or other personal identifying information was redacted from the document prior to production. As a Defendant in aclass action lawsuit pending against DuPont in the West Virginia State Court in which we serve as Class counsel, DuPont also has the right to mark documents produced in that case as falling under the terms ofa Stipulated Protective Order that allow parties to limit distribution of documents,ifthey qualify as documents for which "Confidential Business Information" (CBI), protection would be available under, among other provisions, 40 C.F R. Part 2, Subpart B. None of the enclosed documents have been stamped "confidential" by DuPont underthe termsofthat Stipulated Protective Order.